We’re still looking forward to generic Seroquel being released in a couple of weeks, but it looks like AstraZeneca’s is not going to let its moneymaker go down without a fight. AstraZeneca’s has filed for an injunctions against the U.S. Food and Drug Administration which would block generic Seroquel from hitting the market until until December 2, 2012.
AstraZeneca’s patent on Seroquel is due to expire on March 26th, which means that generic Seroquel is still currently scheduled to hit the market in less than two weeks. It looks like this injunction is AstraZeneca’s last ditch effort to keep generic Seroquel for a while longer, and analysts are calling it a longshot. Still with brand-name Seroquel currently costing almost $250 a month, you can be sure that we’ll be watching this one like a hawk!
- AstraZeneca Stopped from Blocking Generic Seroquel
- Generic Versions of Seroquel Will Be Released in 2016
- Finding Cheaper, More Affordable Seroquel…. Somewhere
- Pfizer Files Lawsuit to Block Low-Cost, Generic Lipitor… When Will Generic Lipitor Hit the Market?
- Generic Drugs: 7 Top Prescription Drugs Going Off Patent Next Year